| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 06/21/2001 | CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/19/2001 | US6248754 Psychological disorders |
| 06/19/2001 | US6248738 Isoquinolines as urokinase inhibitors |
| 06/14/2001 | WO2001042315A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2646567A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process |
| 06/13/2001 | EP1106179A2 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/13/2001 | CN1067070C Coralyne analogs as topoisomerase inhibitors |
| 06/07/2001 | WO2001040192A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | WO2001040191A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/07/2001 | WO2001030749B1 Novel compounds |
| 06/07/2001 | CA2393265A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | CA2393012A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/06/2001 | EP1104755A1 Process for the preparation of (S)-N-tertbutyl-1,2,3,4- tetrahydroisoquinoline-3-carboxamide |
| 06/06/2001 | EP1104404A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 06/06/2001 | EP0888346B1 Coralyne analogs as topoisomerase inhibitors |
| 06/06/2001 | EP0873329B1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 06/06/2001 | CN1298399A Substituted alxoxycarbonyl compounds |
| 06/06/2001 | CN1298299A Antibacterial agents |
| 06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
| 06/05/2001 | US6242462 Novel decahydroisoquinoline derivatives which are selective glur5 receptor antagonists. |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO2000005214A3 Isoquinolines as urokinase inhibitors |
| 05/30/2001 | CN1066329C Preparation of drug composition |
| 05/29/2001 | US6239296 Process for a phenylthiobutyl-isoquinoline and intermediates therefor |
| 05/29/2001 | US6239179 N-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 05/29/2001 | US6239143 5-HT7 receptor antagonists |
| 05/25/2001 | WO2001035917A1 Compositions for dyeing keratinous fibres containing 3-amino pyrazolo-[1,5-a]-pyridines, dyeing method, novel 3-amino pyrazolo-[1,5-a]-pyridines |
| 05/25/2001 | WO2000077027A3 Serine protease inhibitors |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2001 | CA2391980A1 Compositions for dyeing keratinous fibres containing 3-amino pyrazolo-[1,5-a]-pyridines, dyeing method, novel 3-amino pyrazolo-[1,5-a]-pyridines |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235752 Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors |
| 05/22/2001 | US6235748 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 05/17/2001 | WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | CA2388593A1 Bicyclic and tricyclic heteroaromatic compounds |
| 05/16/2001 | EP1099692A1 N,n-substituted cyclic amine derivatives |
| 05/16/2001 | EP1099438A2 Use of APO B secretion/MTP inhibitors |
| 05/16/2001 | EP1098864A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP1039886A4 Hiv/fiv protease inhibitors having a small p3 residue |
| 05/10/2001 | WO2001032626A1 Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 05/10/2001 | WO2001032625A1 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/10/2001 | WO2001032624A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/09/2001 | EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/09/2001 | CN1294577A 钾通道抑制剂 Potassium channel inhibitors |
| 05/03/2001 | WO2001030749A1 Novel compounds |
| 05/03/2001 | WO2001030734A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 05/03/2001 | WO2001010839A3 Multivalent substituted ketoamides and amides for treating hair loss |
| 05/02/2001 | EP1095022A1 Retroviral protease inhibitors |
| 05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/01/2001 | CA2197178C Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029013A1 Process for preparing oxazolines from tetrahydrofurans |
| 04/25/2001 | EP1093368A1 INDOLE AND TETRAHYDROISOQUINOLINE CONTAINING $g(a)-KETO OXADIAZOLES AS SERINE PROTEASE INHIBITORS |
| 04/25/2001 | CN1292791A Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 04/24/2001 | US6222072 Racting imine with hydride reagent in presence of optically active metal compound, wherein hydride reagent is a metal hydride, reagent that undergoes metal exchange, metal trialkoxy hydride complex or metal(tricarboxylic acid)hydride |
| 04/24/2001 | US6221866 Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament, and pharmaceutical formulations containing them |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/19/2001 | WO2001002366A3 Substituted isoquinoline derivatives and their use as inticonvulsants |
| 04/19/2001 | US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis |
| 04/18/2001 | EP1091960A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents |
| 04/17/2001 | US6218404 Therapy and prophylaxis of neuronal loss associated with stroke, ischemia, cns trauma, hypoglycemia and surgery, neuro-degenerative diseases including alzheimer's disease, amyotrophic lateral sclerosis, huntington's disease |
| 04/17/2001 | US6218393 Anthranilic acid derivatives as multi drug resistance modulators |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/11/2001 | EP1089976A1 Method of preparing 5- or 8-bromoisoquinoline derivatives |
| 04/11/2001 | EP0882020B1 Process for the preparation and isolation of atracurium besylate |
| 04/10/2001 | US6215030 Catalytic reduction of acids, esters and anhydrides to alcohols |
| 04/05/2001 | WO2001022968A1 Anticancer agents |
| 04/04/2001 | EP1087981A2 Prenyl transferase inhibitors |
| 04/03/2001 | US6211241 Aryl sulfonamides and sulfamide derivatives and uses thereof |
| 04/03/2001 | CA2102772C Azetidinone compound and process for preparation thereof |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021169A1 Mch antagonists |
| 03/29/2001 | CA2383147A1 Mch antagonists |
| 03/28/2001 | EP1086095A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086085A1 INHIBITORS OF p38 |
| 03/28/2001 | EP1086084A1 Tetraisoquinololine derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/27/2001 | US6207672 Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids |
| 03/27/2001 | US6207667 1,3 diazines with platelet-derived growth factor receptor inhibitory activity |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/22/2001 | WO2001019798A2 INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | CA2385589A1 Inhibitors of factor xa |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/20/2001 | US6204296 Patient oxygenation using stabilized fluorocarbon emulsions |
| 03/20/2001 | US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |